Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered T-cell differentiation in Non-ST segment elevation acute coronary syndrome

Luigi Marzio Biasucci, Filippo Crea, Giovanna Liuzzo, Chiara Zara, Anna Severino, Davide Flego, Aureliano Ruggio, Daniela Pedicino, Ada Francesca Giglio, Francesco Trotta, Claudia Lucci, Domenico D'Amario, Ramona Vinci, Eugenia Pisano, Giulio La Rosa

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

Atherosclerosis is a chronic inflammatory disease characterized by a complex interplay between innate and adaptive immunity. Dendritic cells (DCs) play a key role in T-cell activation and regulation by promoting a tolerogenic environment through the expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme involved in tryptophan catabolism. IDO expression and activity was analyzed in monocytes derived DCs (MDDCs) from non-ST segment elevation myocardial infarction (NSTEMI) patients, stable angina (SA) patients and healthy controls (HC) by real-time quantitative polymerase chain reaction (RT-qPCR) before and after in vitro maturation with lipopolysaccharide (LPS). The amount of tryptophan catabolite; kynurenine; was evaluated in the culture supernatants of mature-MDDCs by ELISA assay. Autologous mixed lymphocyte reaction (MLR) between mature-MDDCs and naïve T-cells was carried out to study the differentiation towards T-helper 1 (Th1) and induced regulatory T-cells (iTreg). Analysis of IDO mRNA transcripts in mature-MDDCs revealed a significant reduction in cells isolated from NSTEMI (625.0 ± 128.2; mean ± SEM) as compared with those from SA (958.5 ± 218.3; p = 0.041) and from HC (1183.6 ± 231.6; p = 0.034). Furthermore; the concentration of kynurenine was lower in NSTEMI patients (2.78 ± 0.2) and SA (2.98 ± 0.25) as compared with HC (5.1 ± 0.69 ng/mL; p = 0.002 and p = 0.016; respectively). When IDO-competent mature-MDDCs were co-cultured with allogeneic naïve T-cells, the ratio between the percentage of generated Th1 and iTreg was higher in NSTEMI (4.4 ± 2.9) than in SA (1.8 ± 0.6; p = 0.056) and HC (0.9 ± 0.3; p = 0.008). In NSTEMI, the tolerogenic mechanism of the immune response related to IDO production by activated MDDCs is altered, supporting their role in T-cell dysregulation.
Lingua originaleEnglish
pagine (da-a)63-63
Numero di pagine1
RivistaInternational Journal of Molecular Sciences
Volume19
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • Acute coronary syndromes
  • Catalysis
  • Computer Science Applications1707 Computer Vision and Pattern Recognition
  • IDO
  • Immune system
  • Inorganic Chemistry
  • Molecular Biology
  • Myeloid derived dendritic cells
  • Organic Chemistry
  • Personalized medicine
  • Physical and Theoretical Chemistry
  • Spectroscopy
  • T-cell differentiation

Fingerprint Entra nei temi di ricerca di 'Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered T-cell differentiation in Non-ST segment elevation acute coronary syndrome'. Insieme formano una fingerprint unica.

Cita questo